health π¬ AI helps target tough pancreatic cancer protein
Mayo Clinic researchers used AI to find a GIPC1 inhibitor that slows pancreatic tumor growth. This study, done with Sravathi AI Technology, screened nearly 40,000 compounds. The experimental drug slowed tumors and boosted gemcitabine's effect in lab models. Pancreatic cancer is hard to treat due to rapid resistance to therapies. Further research is needed before this potential treatment can reach human trials. π¬